Today: 9 June 2026
Browse Category

NYSE:DOCN 5 November 2025 - 19 January 2026

Cloud computing stocks face Tuesday test after Trump tariff threat rattles big tech

Cloud computing stocks face Tuesday test after Trump tariff threat rattles big tech

Cloud-focused ETFs fell Friday, with CLOU down 1.34% to $21.34, WCLD off 2.05%, and SKYY losing 0.9%, after U.S. tariff threats and declines in European tech stocks. Nasdaq 100 futures dropped as U.S. markets stayed closed for Martin Luther King Jr. Day. Microsoft reports earnings Jan. 28, Alphabet on Feb. 4. Investors await updates on cloud demand and spending.
19 January 2026
········
DigitalOcean Stock in December 2025: AI Pivot, Earnings Beat and What Comes Next for DOCN

DigitalOcean Stock in December 2025: AI Pivot, Earnings Beat and What Comes Next for DOCN

DigitalOcean shares closed at $48.30 on December 5, 2025, near a 52-week high, valuing the company at about $4.4 billion. Q3 revenue rose 16% to $230 million, with net income boosted by a tax benefit and debt retirement. AI revenue more than doubled year-over-year for the fifth straight quarter. Institutional ownership increased slightly, while options data shows a bullish tilt.
8 December 2025
···
DigitalOcean Stock Skyrockets on AI Momentum and Earnings Beat – What’s Next for DOCN?

DigitalOcean Stock Skyrockets on AI Momentum and Earnings Beat – What’s Next for DOCN?

DigitalOcean shares jumped over 15% to the mid-$45 range in early trading Nov. 5 after Q3 results beat estimates and full-year guidance was raised. Q3 revenue rose 16% to $230 million, with adjusted EPS of $0.54. Large-customer revenue climbed 41% year-over-year. Management now expects 2025 revenue of $896–$897 million, about 16% growth.
5 November 2025
····

Stock Market Today

  • Soybean Prices Dip Amid Export Sales and Crop Progress Reports
    June 9, 2026, 9:20 AM EDT. Soybeans experienced modest declines on Monday, with futures dropping up to 5¾ cents and the national average cash price falling to $10.57 1/2 per bushel. The USDA reported a private sale of 264,000 metric tons for the 2026/27 marketing year. Weekly export shipments fell 21.2%, totaling 398,186 MT, led by Egypt, China, and Mexico. Crop progress shows 92% planted and emergence ahead of schedule, though crop conditions slipped slightly. Marketing year exports remain 20.3% below last year, reflecting pressure on prices. Soymeal futures declined 20 cents, and soy oil futures showed mixed moves. These indicators suggest cautious market sentiment amid ongoing supply and demand factors shaping the soybean market.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Go toTop